United States· US:68982-182_4a2195d5-2603-22a3-4a23-9e31111bde62
Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human)
A medicinal product containing antihemophilic factor human; von willebrand factor human, registered in United States by Octapharma USA Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ANTIHEMOPHILIC FACTOR HUMAN; VON WILLEBRAND FACTOR HUMAN
- Manufacturer
- Octapharma USA Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 12, 2026
Packs & prices · 4
- ndc1168982182015 mL in 1 VIAL (68982-182-01)
- ndc11689821820210 mL in 1 VIAL (68982-182-02)
- ndc1168982-182-01
- ndc1168982-182-02
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Antihemophilic factor human; von willebrand factor human in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandHaemateAbacus Medicine A/S
- CzechiaFANHDIInstituto Grifols, S.A., Barcelona
- SwedenHaemate 1000 IE FVIII/ 2400 IE VWF Pulver och vätska till injektions-/infusionsvätska, lösningCSL Behring GmbH
- NorwayHaemateCSL Behring GmbH
- IrelandVoncento 1000 IU/2400 IU Powder and solvent for solution for injection/infusionCSL Behring GmbH
- IcelandVoncentoCSL Behring GmbH*
- CanadaHUMATE-PCSL BEHRING CANADA INC
- GermanyHaemate PCsl Behring Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Haemate P, Immunate
- Belgium · Haemate P, Wilate
- Bulgaria · Wilate, Имунейт
- Cyprus · Haemate P, Immunate
- Czechia · Fanhdi, Haemate P
- Germany · Haemate P, Immunate
- Denmark · Haemate, Wilnativ
- Estonia · Haemate, Immunate
- Spain · Fanhdi, Haemate P
- Finland · Haemate, Haemwill
- France · Eqwilate
- United Kingdom (Northern Ireland) · Alphanate, Dried Factor Viii Fraction Type 8y Bio Products Laboratory
- Greece · Haemate P
- Croatia · Fanhdi, Haemate P
- Hungary · Haemate P, Immunate S/D
- Ireland · Wilate
- Iceland · Voncento
- Italy · Alphanate, Fanhdi
- Liechtenstein · Voncento
- Lithuania · Haemate, Immunate
- Luxembourg · Haemate P, Wilate
- Latvia · Haemate, Immunate
- Malta · Immunate, Wilate
- Netherlands · Haemate P, Wilate
- Norway · Haemate, Voncento
- Poland · Fanhdi, Haemate P
- Portugal · Haemate P, Immunate
- Romania · Haemate P, Immunate
- Sweden · Haemate, Wilate
- Slovenia · Haemate P, Immunate
- Slovakia · Fanhdi, Haemate P
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/011d07e9-9fde-4936-aba0-bdedd3fa5c08 GET /v1/drugs/011d07e9-9fde-4936-aba0-bdedd3fa5c08?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "100; 100",
"substance": "ANTIHEMOPHILIC FACTOR HUMAN; VON WILLEBRAND FACTOR HUMAN",
"productndc": "68982-182",
"dosage_form": "POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "[iU]/mL; [iU]/mL",
"application_number": "BLA125251",
"marketing_category": "BLA"
}See everything about antihemophilic factor human; von willebrand factor human.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.